MAGENTA THERAPEUTICSCS INC
MAGENTA THERAPEUTICSCS INC
Acción · US55910K1088 · MGTA · A2JPD6 (XNMS)
Resumen Indicadores financieros
Sin cotización
n/a

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
- - - - 0,00 % 0,00 % -92,30 %

Perfil de la empresa para MAGENTA THERAPEUTICSCS INC Acción

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Fondos invertidos

Los siguientes fondos han invertido en: MAGENTA THERAPEUTICSCS INC invertido:

Fondo
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millones
12,52
Porcentaje (%)
0,03 %

Datos de la empresa

Nombre MAGENTA THERAPEUTICSCS INC
Empresa Magenta Therapeutics, Inc.
Símbolo MGTA
Sitio web https://www.magentatx.com
Mercado principal XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2JPD6
ISIN US55910K1088
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Stephen F. Mahoney J.D., MBA
Capitalización de mercado 42 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 100 Technology Square, 02139 Cambridge
Fecha de OPV 2018-06-21

Símbolos de cotización

Nombre Símbolo
NASDAQ MGTA

Otras acciones

Los inversores que tienen MAGENTA THERAPEUTICSCS INC también tienen las siguientes acciones en su cartera:
AMC NETWORKS INC - CLASS A
AMC NETWORKS INC - CLASS A Acción
AMGEN INC
AMGEN INC Acción
AUTODESK INC
AUTODESK INC Acción
BANK OF AMERICA CORPORATION 2.75% & CMS LKD NTS 04/01/30
BANK OF AMERICA CORPORATION 2.75% & CMS LKD NTS 04/01/30 Bono
BIOGEN INC
BIOGEN INC Acción
CISCO SYSTEMS INC
CISCO SYSTEMS INC Acción
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Acción
EBAY INC
EBAY INC Acción
INTEL CORP
INTEL CORP Acción
LB.HESS.-THR.IS.03B/22
LB.HESS.-THR.IS.03B/22 Bono
MICROSOFT CORP
MICROSOFT CORP Acción
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Acción
UP FINTECH HOLDING LIMITED - AMERICAN DEPOSITARY SHARES REPRESENTING FIFTEEN CLASS A
UP FINTECH HOLDING LIMITED - AMERICAN DEPOSITARY SHARES REPRESENTING FIFTEEN CLASS A Certificado de depósito
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025